2014
DOI: 10.1152/ajpheart.00978.2013
|View full text |Cite
|
Sign up to set email alerts
|

Vasodilator responses to acetylcholine are not mediated by the activation of soluble guanylate cyclase or TRPV4 channels in the rat

Abstract: The effects of 1H-[1,2,4]-oxadizaolo [4,3-]quinoxaline-1-one (ODQ), an inhibitor of the activation of soluble guanylate cyclase (sGC) on responses to NO donors acetylcholine (ACh) and bradykinin (BK) were investigated in the pulmonary and systemic vascular beds of the rat. In these studies the administration of ODQ in a dose of 5 mg/kg iv attenuated vasodilator responses to five different NO donors without inhibiting responses to ACh and BK in the systemic and pulmonary vascular beds of the rat. Vasodilator re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
13
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(16 citation statements)
references
References 51 publications
(100 reference statements)
3
13
0
Order By: Relevance
“…The observation that blood pressure responses to the H 2 S donors in the intact chest rat are not attenuated by glybenclamide or L-NAME does not mean that K ATP channels or NO is not involved in mediating responses in some local vascular segments or regions. The present data indicate that K ATP channels or NO does not play a major role in mediating the overall decreases in systemic arterial pressure in response to intravenous injections of the H 2 S donors in the rat and are similar to data in eNOS knockout mice where the hypotensive response to acetylcholine is not impaired but that vasodilator responses in some regional vascular segments isolated from eNOS knockout mice are attenuated (16,25,33).…”
Section: Discussionsupporting
confidence: 85%
See 2 more Smart Citations
“…The observation that blood pressure responses to the H 2 S donors in the intact chest rat are not attenuated by glybenclamide or L-NAME does not mean that K ATP channels or NO is not involved in mediating responses in some local vascular segments or regions. The present data indicate that K ATP channels or NO does not play a major role in mediating the overall decreases in systemic arterial pressure in response to intravenous injections of the H 2 S donors in the rat and are similar to data in eNOS knockout mice where the hypotensive response to acetylcholine is not impaired but that vasodilator responses in some regional vascular segments isolated from eNOS knockout mice are attenuated (16,25,33).…”
Section: Discussionsupporting
confidence: 85%
“…For the measurement of pulmonary arterial pressure, a specially designed 3-F single-lumen catheter with a curved tip and radioopaque marker was passed from the right jugular vein into the main pulmonary artery under fluoroscopic guidance (Picker-Surveyor Fluoroscope) as described previously (19,(33)(34)(35). Pulmonary arterial pressure was measured with a Namic Perceptor DT pressure transducer and data acquisition system and stored on the PC.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Both ECs and SMCs from PAs showed a strong expression of PKG (FigureĀ 5B). Similar to Lā€NNA, GC inhibitor ODQ (3Ā Ī¼mol/L)44 and PKG inhibitor Rpā€8ā€Brā€PETā€CGMPS (PET; 30Ā Ī¼mol/L)45 increased the baseline sparklet activity by ā‰ˆ2ā€fold (FigureĀ 5C), confirming that GCā€PKG signaling constitutively inhibits TRPV4 channels in PA endothelium. In the presence of GC or PKG inhibitor, Lā€NNA was unable to further increase the activity of TRPV4 sparklets (FigureĀ 5C, left ).…”
Section: Resultsmentioning
confidence: 65%
“…mAChR activation of the endothelium reduces pulmonary arterial tension or vascular pressures in multiple animals, including mice, rats, and sheep in addition to humans (Storme et al, 1999;Peyter et al, 2008;Rowell et al, 2009;Pankey et al, 2014). Endothelial cell mAChR stimulation induces intracellular Ca 2+ responses that activate multiple signaling pathways, including endothelial nitric oxide synthase (eNOS), phospholipase A 2 (PLA 2 ), and myoendothelial junctions (Norel et al, 1996;Walch et al, 2001;Papamatheakis et al, 2013).…”
Section: Introductionmentioning
confidence: 99%